NEW YORK – Metagenomics technology company IDbyDNA announced Wednesday it has raised $20 million in a Series B financing round. Artis Ventures led the round, joined by Genesys Capital and other investors.
The firm said in a statement it will use the funds to enhance and expand its Explify software platform and to support the opening of a CLIA-approved commercial laboratory.